Steven Hoffman’s Post

This week, we're teaming up with Resistomap to dive into what AMR is and why monitoring it in the environment is a crucial first step in combating its spread. Follow our posts to learn more and join the conversation! #WAAW2024

We are thrilled to be a Sponsor of the 7th World Bronchiectasis Conference, taking place in Dundee, Scotland from July 4th to 6th, 2024. Zambon is proud to be present at this important event, supporting and advancing research and care in bronchiectasis. The World Bronchiectasis Congress brings together around 903 participants, including 73 speakers from 45 nationalities, and features 147 posters and 161 abstracts. This three-day event focuses on bronchiectasis and non-tuberculous mycobacterial infections, fostering a global community of scientists and researchers dedicated to sharing the latest research and innovations. Bronchiectasis is a serious condition where the small airways of the lungs are widened, scarred, and inflamed, making it difficult to clear mucus from the lungs and leading to repeated lung infections. #WorldBronchiectasisConference #ZambonAtWBC #BronchiectasisResearch #GlobalHealth2024 #LungHealthInnovation

Another must read document by my former WHO Regional Office for Europe colleagues from the Control of #AMR program! This is a very useful tool for countries and institutions embarking on a journey of controlling AMR ☝️

#AMR is an important issue - if you want an update on progress being made on addressing the ‘AMR silent pandemic’ do register for this free webinar. Looking forward to chairing the webinar, insightful updates from the expert panel and an engaging Q&A.

We continue to lead innovative efforts in the mitigation of antimicrobial resistance (AMR) globally. Some of our recent initiatives include: 1. Global Campaign "From People to Leaders: Act on AMR NOW!": Our campaign has garnered 125 signatures from communities and civil society groups across the world. This movement aims to mobilize support and press world leaders for concrete action on AMR at the upcoming UN General Assembly High-Level Meeting in September 2024. Join us in the fight against AMR! Learn more and get involved: https://lnkd.in/dx4cchYe 2. New Research Report: We've published a report on "Community Engagement and AMR: Insights from the Asia Pacific Region." This study highlights the critical role of community-based approaches in addressing AMR, particularly in low- and middle-income countries. Download now: https://lnkd.in/gzNsmc65 3. Global Governance Roundtable: ReAct recently held a roundtable discussion on "Improving the future governance of the global response to antibiotic resistance" in Uppsala, bringing together experts and representatives from low- and middle-income countries. 4. ReAct Toolbox: Our comprehensive resource for One Health action on antibiotic resistance continues to provide valuable information across six key areas: Understand, Raise Awareness, Measure, Rational Use, Prevent Infection, and Policy. Visit: https://lnkd.in/dCAvwmX Join us in the fight against AMR. Every action counts in preserving the effectiveness of antibiotics for future generations. Read more: https://lnkd.in/gXMJK9B6 #AntibioticResistance #OneHealth #AMR #ActOnAMRNow

🏥 BIOPIX DNA TECHNOLOGY S.A., indispensable UniHealth EU partner specializes in creating #innovative devices, tailored specifically for the UniHealth EU program. 🔬 The BIOPIX DNA TECHNOLOGY S.A. device incorporates multi-channel fluorescence detection, allowing simultaneous monitoring of multiple contaminants within a sample. 🔍 This is crucial for UniHealth EU, enabling comprehensive assessments of human samples and #quality detecting threats like #viruses in one test. 🧫 ⚕ 💊 The #Pebble device ensures ease of use, with customizable settings for different infectious diseases monitoring scenarios. 🛠️💻 Its #portability and #affordability make BIOPIX DNA TECHNOLOGY S.A. ideal for the needs of global pandemic preparedness. 🚀🏞️ The device’s cost-effectiveness allows large-scale deployment, making it a game-changer for extensive monitoring efforts. 🌍 #UniHealth #POCdiagnostics #ivdr #globalpartnership #HorizonEU #ResearchImpactEU 🎯 Together, we can change the scene in pathogens detection and infectious diseases prevention. Stay tuned:

📺 Fantastic to see antimicrobial resistance (AMR) and its already significant impact on UK patients being discussed on BBC's The One Show. This 8-minute clip shows how BIVDA member Sysmex Astrego AB's Longitude Prize-winning PA-100 AST System works and why, in the words of Professor Dame Sally Davies, it is a 'game-changer' in tackling AMR 👇 https://lnkd.in/eee-D5a3 #AMR #Diagnostics #LongitudePrize

Let’s discuss how diagnostics can revolutionize vaccine strategies and protect communities worldwide. 🎉 Join us this Monday, November 18, at 16:30 CET for a Gavi Brown Bag Seminar on Diagnostics for Targeted Vaccination! 🌍 I will be presenting on improved diagnostics to advance the roadmap to #DefeatMeningitis on behalf of our team (Joaquin Baruch, Katya Fernandez, Liza Coyer, Nicolò Binello) We will focus on: - Improving lumbar puncture (LP) practices and laboratory capacity in countries with limited resources. - Progress in developing rapid diagnostic tests (RDTs) to enable quicker and more effective outbreak responses. - Strategic next steps to enhance CSF collection, deploy diagnostics, and bridge current gaps in meningococcal disease testing. Other presentations will cover diagnostic innovations for yellow fever, cholera, measles and rubella, and typhoid, demonstrating how these advancements drive better-targeted vaccination and outbreak responses worldwide. 🗓 When: Monday, 18 November 2024, 16:30–18:00 CET 📍 Where: Zoom Webinar / Geneva (Global Health Campus) 💡 How to join: Register here

💡 Antimicrobials: A Precious Resource Worth Protecting As we mark Antimicrobial Resistance (AMR) Awareness Week, I find myself reflecting on Stanford’s mission statement, which frames antimicrobials as precious resources. This resonates deeply with the global call to action during this pivotal week—to recognize the urgent need for antimicrobial stewardship to combat the growing threat of resistance. Stanford’s mission to “improve patient outcomes and safety now and in the future” through optimal use and sustainability of antimicrobials emphasizes the importance of collaboration at all levels—local, national, and global. It reminds us that stewardship isn’t just about today’s challenges; it’s about safeguarding these life-saving tools for generations to come. Empowering stakeholders to be stewards of this resource and training the next generation of leaders are steps that echo the very essence of AMR Awareness Week. It’s a reminder that this fight requires all of us—healthcare professionals, policymakers, researchers, and communities—to work together to curb resistance. As we reflect on this week’s theme, let’s remember: Every action counts. Whether it’s prescribing wisely, raising awareness, or supporting global stewardship efforts, we all have a role to play in protecting antimicrobials for the future. How are you contributing to this global fight during AMR Week? Let’s share ideas and inspiration! #AntimicrobialResistance #AMRAwarenessWeek #AntimicrobialStewardship #GlobalHealth

Countdown to EMCHD 2024: Only 2 Days Left As we approach the 19th European Meeting on Complement in Human Diseases (EMCHD 2024) in Lübeck, the excitement is building. With just 2 days to go we can't wait to welcome you. Call to Action: If you are attending the satellite symposium, we invite you to comment below with any questions or topics you would like to see discussed during the panel sessions. Your input will help us tailor the discussions to address the most pressing issues in complement research. #EMCHD2024 #Lübeck #ComplementInHumanDiseases #ScientificConference #MedicalResearch #Innovation #Networking #LübeckIsReadyAreYou